An open label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector) in HIV-1-infected subjects

Hum Gene Ther. 1995 Jul;6(7):941-55. doi: 10.1089/hum.1995.6.7-941.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II

MeSH terms

  • Clinical Protocols
  • Female
  • Gene Products, env / genetics*
  • Gene Products, env / therapeutic use
  • Gene Products, rev / genetics*
  • Gene Products, rev / therapeutic use
  • Genetic Therapy*
  • Genetic Vectors*
  • HIV Infections / therapy*
  • HIV-1 / genetics*
  • Humans
  • Male
  • Risk Factors
  • Safety
  • rev Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, env
  • Gene Products, rev
  • rev Gene Products, Human Immunodeficiency Virus